Anthony Afum-Adjei Awuah

Anthony started his career with a degree in Biochemistry from the Department of Biochemistry and Biotechnology, KNUST and joined at KCCR to do his PhD in Immunology, investigating the role of immune modulatory molecules in the immunopathogenesis of tuberculosis. After his PhD, he started his postdoc at KCCR where he developed means to improve the use of interferon gamma release assay (IGRA) to diagnose TB in children.

He is a researcher with experience in clinical research and community-based studies, including drug and vaccine clinical trials for infectious diseases.

He has had other postdoc training with Centre Muraz in Burkina through the West Africa Health Research Network and GSK vaccine in Siena, Italy through WHO/TDR fellowship grant. He was part of the 2017 cohort of the Next Generation Scientist program to train young emerging scientists in clinical research at the headquarters of Novartis Pharma in Basel, Switzerland. Anthony has extensive experience in the design, planning and conduct of clinical research from field to lab.